When all other treatments failed to cure the two infants of leukemia, doctors at London’s Great Ormond Street Hospital used genetically engineered immune cells from a donor to treat them. Reportedly the children are now in remission. Albeit a medical first, some researchers note that because the children received chemotherapy prior to the experimental treatment, "they failed to show the cell treatment actually cured the kids."
“The patient could be treated immediately, as opposed to taking cells from a patient and manufacturing them,” says Julianne Smith, vice president of CAR-T development for Cellectis, which specializes in supplying universal cells.
In the off-the-shelf approach, blood is collected from a donor and then turned into “hundreds” of doses that can then be stored frozen, says Smith. “We estimate the cost to manufacture a dose would be about $4,000,” she says. That’s compared to a cost of around $50,000 to alter a patient’s cells and return them.
|“If there’s any kind of future for 'designer babies', it might look something like this.”|
|Cancer Off-Switch Gene Found|
|#OilSpill: How Bad it Could Get|
|How Toilet Paper is Made|
|Swine Flu vs. Normal Trip to Mexico|
|"There’s a galactic gold rush brewing."|
|“What if energy generation was a consumer electronic you could order off Amazon?”|
|Making a Movie Inside a Video Game|
|Fast, Clean, Cost-Effective Metal 3D-Printing|
|"An unabashed love letter to the 1982 motion picture Blade Runner."|
|Google Map Shows You the Most Photographed Areas of the World|
|"You only need about 100 miles by 100 miles of solar panels to power the entire United States."|
|"A helpful guide created by an unqualified individual."|
|"A real-time surveillance machine that has been developed for online advertising is rapidly expanding into other fields."|
|“Robots should be fitted with an 'ethical black box' to keep track of their decisions.”|